News Briefing channel feed – Endpoints News

News Briefing channel feed

Seattle and Daiichi Sankyo at each other's throats; UC Berkeley, UCSF and the University of Washington launch Weill Neurohub

6 years ago

FDA’s Project Orbis may expand to Singapore and Switzerland

6 years ago

Amgen axes 149 of its staff in Cambridge office; Evotec, MilliporeSigma enter research pact

6 years ago

Teva spinout raises $85M in IPO; Novartis beefs up generics unit with $440M deal

6 years ago

Sarepta CEO disputes FDA revenge narrative; Takeda posts long-term data on key Shire drug

6 years ago

ObsEva shares crater after PhIII fail; Allena Pharma unveils positive late-stage data

6 years ago

Regeneron plans $1B stock buyback; Merck partner touts PhIIb results for Keytruda combo in pancreatic cancer

6 years ago

Steve Kafka joins Section 32 as managing partner; Takeda auctions off $660M drug portfolio in bid to reduce post-Shire M&A debt load

6 years ago

Tmunity teams up with Oncora Medical; T3D receives additional funding for Alzheimer's study

6 years ago

AbbVie showcases positive PhIII data for Rinvoq; RAPT prices on low end for IPO

6 years ago

Sanifit touts positive PhIIb data; REGENXBIO licenses Clearside Biomedical tech

6 years ago

Dupixent cleared for chronic rhinosinusitis in EU; FDA grants RMAT status to CARsgen's CAR-T

6 years ago

FDA accepts Heron's painkiller re-submission; splits Blueprint Medicines' NDA for avapritinib

6 years ago

Provention Bio's diabetes drug gains PRIME status; Avrobio earns orphan status

6 years ago

Amgen commits to low-cost Repatha; AZTherapies bags Smith Therapeutics' CAR-Treg tech for neuroinflammation

6 years ago

NeuroRx secures $95M to fund PhIII for NMDA depression drug; Trump revives science advisory council

6 years ago

CD47 player Trillium chops discovery efforts and 40% of staff; Brii Bio inks deal to bring antibiotics to China

6 years ago

Drug companies reach $260M settlement just ahead of opioid trial; Oyster Point set terms for $85M IPO

6 years ago

Ansun Biopharma closes $80M Series B; RedHill Biopharma ties up with Cosmo Pharmaceuticals

6 years ago

After 13% discount Innate Pharma raises $69M; AZTherapies bags $26.3M from Series C financing round

6 years ago

Amarna raises €10M to push gene therapy platform into clinic; Editas Medicine, AskBio join forces

6 years ago

Checkmate Pharmaceuticals brings two new execs on board; Takeda sheds 30 drugs, gains $200M in Acino deal

6 years ago

FDA requests additional time for Flexion's sNDA; Genentech releases data for PhIII study of Rituxan

6 years ago

Northwest Bio still hanging on; Five Prime's latest round of layoffs claims 70

6 years ago

First page Previous page 45 46 474849 50 51 Next page Last page